Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.41 |
| ▸ | CES1 | P23141 | 2/20 | 0.41 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | P2RX7 | Q99572 | 9/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MAP2K4 | P45985 | 1/20 | 0.33 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.33 |
| ▸ | MAPKAPK3 | Q16644 | 1/20 | 0.33 |
| ▸ | MAPK6 | Q16659 | 1/20 | 0.33 |
| ▸ | ALKBH1 | Q13686 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL522658 | 0.89 | APOBEC3G (0.36) | APOBEC3G | |
| SCHEMBL3310848 | 0.85 | CES2 (0.38) | CES2CES1RIPK1CA2P2RX7 | |
| SCHEMBL3144290 | 0.80 | MEP1B (0.39) | CES2CES1RIPK1GPR84 | |
| SCHEMBL6489433 | 0.80 | GPR84 (0.35) | CES2CES1RIPK1GPR84 | |
| SCHEMBL20607946 | 0.80 | CES2 (0.33) | CES2CES1RIPK1GPR84MAPK1 | |
| SCHEMBL15903837 | 0.80 | CES2 (0.38) | CES2CES1RIPK1CA2P2RX7 | |
| SCHEMBL1241765 | 0.80 | CES2 (0.38) | CES2CES1RIPK1CA2P2RX7 | |
| SCHEMBL16880602 | 0.79 | APOBEC3G (0.31) | APOBEC3G | |
| SCHEMBL2974841 | 0.79 | CES2 (0.41) | CES2CES1RIPK1CA2P2RX7 | |
| SCHEMBL4621767 | 0.78 | MAPK1 (0.36) | RIPK1MAPK1MAP2K4MAPKAPK2MAPKAPK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115745766-B | Preparation method of trifluorobenzaldehyde and trifluorobenzyl bromide | 兰州康鹏威耳化工有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-115745766-A | Preparation method of trifluorobenzaldehyde and trifluorobenzyl bromide | 兰州康鹏威耳化工有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-112341546-B | Preparation method of fluorinated biomass membrane material | 北京化工大学 | 2022-07-05 | — | — | CN | claimed |
| CN-112341546-A | Preparation method of fluorinated biomass membrane material | 北京化工大学 | 2021-02-09 | — | — | CN | claimed |
| CN-111253415-A | Norcantharidin carboxylic acid trifluorobenzyl ester and synthetic method and application thereof | 遵义医科大学 | 2020-06-09 | — | — | CN | claimed |
| US-8952083-B2 | Fluorocopolymer composition and its production process | ASAHI GLASS COMPANY, LIMITED (JP) | 2015-02-10 | — | — | US | claimed |
| EP-3882235-B1 | PRODUCTION METHOD FOR ISOCYANATE COMPOUND | UNIV KOBE NAT UNIV CORP (JP) | 2025-01-22 | — | — | EP | disclosed |
| EP-4219463-B1 | TERPYRIDINE DIKETONE COMPOUND OR SALT THEREOF, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | SHENZHEN SALUBRIS PHARM CO LTD (CN) | 2025-01-15 | — | — | EP | disclosed |
| EP-4484407-A2 | (METH)ACRYLATE COMPOUND, ADDITIVE FOR OPTICAL RESIN, OPTICAL ELEMENT, AND OPTICAL DEVICE | NIKON CORPORATION (JP) | 2025-01-01 | — | — | EP | disclosed |
| US-12060312-B2 | Production method for isocyanate compound | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2024-08-13 | — | — | US | disclosed |
| US-20240166627-A1 | Terpyridinedione compound or salt thereof, and preparation method and application thereof | SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. (CN) | 2024-05-23 | — | — | US | disclosed |
| CN-115745766-B | Preparation method of trifluorobenzaldehyde and trifluorobenzyl bromide | 兰州康鹏威耳化工有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-116648244-B | Terpyridyl dione compound or salt thereof, and preparation method and application thereof | 深圳信立泰药业股份有限公司 | 2023-12-15 | — | — | CN | disclosed |
| US-6452056-B1 | REDUCING FLUORINATED BENZONITRILE TO A BENZYLAMINE WHICH IS REPLACED WITH A HYDROXYL GROUP | ASAHI GLASS COMPANY, LIMITED (JP) | 2002-09-17 | — | — | US | disclosed |
| EP-1140759-A1 | POLYMERIZABLE HALOGENATED VINYL ETHERS | AlliedSignal Inc. (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2001068619-A1 | 5-AMIDE SUBSTITUTED DIARYLAMINES AS MEX INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2001-09-20 | — | — | WO | disclosed |
| EP-1114809-A1 | PROCESS FOR THE PREPARATION OF FLUOROBENZYL DERIVATIVES | Asahi Glass Co., Ltd. (JP) | 2001-07-11 | — | — | EP | disclosed |
| WO-2000037403-A1 | POLYMERIZABLE HALOGENATED VINYL ETHERS | ALLIEDSIGNAL INC. (US) | 2000-06-29 | — | — | WO | disclosed |
| US-5661186-A | MELATONERGIC EFFECT; CENTRAL NERVOUS SYSTEM DISODERS | BRISTOL-MYERS SQUIBB CO. (US) | 1997-08-26 | — | — | US | disclosed |
| EP-0728738-A1 | Tetralinyl- and indanyl-ethylamides having melatonergic activity | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-08-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240166627-A1 | Terpyridinedione compound or salt thereof, and preparation method and application thereof | TNF, MAPKAPK2, MAPK1 | CES2 3991/4885CES1 3473/4885RIPK1 326/4885 |
| US-12060312-B2 | Production method for isocyanate compound | IDH2, CBR3, IDH3A | CES2 1339/4885CES1 2811/4885RIPK1 4133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.